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Blood cells are generated in the bone
marrow through a process called
hematopoiesis by which the host contin-
uously maintains adequate numbers of
terminally differentiated cells of different
lineages. Hematopoiesis is arranged as
a hierarchy whereby the mature ele-
ments of the hematopoietic system are
derived in a clonal fashion from
hematopoietic stem cells (HSC). The
stem cell compartment consists of long-
term reconstituting HSCs (LT-HSC),
which alone possess the capacity for
self-renewal as well as the capacity to
form all elements of the mature
hematopoietic system for the life of the
animal, and short-term reconstituting
HSCs (ST-HSC), which can only briefly
form blood cells (Figure 1). The bone
marrow has the ability to markedly
increase the production of blood cells to
compensate for hematological stresses
such as blood loss and infection. The
need to continuously vary production of
different types of lympho-hematopoietic
cells necessitates strict control over rele-
vant committed progenitor cell numbers,
and programmed cell death (PCD)
plays a key role in this homeostasis
(Wickremasinghe and Hoffbrand, 1999).
However, the dose-limiting toxicity of
chemotherapy or γ radiation is the induc-
tion of PCD in hematopoietic progenitor
and/or stem cells leading to anemia,
bleeding, and infections.
PCD is executed by the activation of
a cascade of proteases called caspases
that irreversibly cause the cell to undergo
apoptosis. There are two major apopto-
sis pathways, the death receptor (cas-
pase 8- or 10-dependent) pathway and
the intrinsic death (mitochondrial, cas-
pase 9-dependent) pathway. After activa-
tion of one of the cell death pathways,
the effector caspases (caspases 3, 6,
and 7) then execute the programmed
death of the cell. The former pathway is
triggered by activation of death receptors
of the tumor necrosis receptor (TNF-R)
family such as Fas, while the latter is trig-
gered by cell stresses such as γ radia-
tion. The mitochondrial death machinery
can be mediated by proapoptotic mem-
bers of the bcl-2 family such as bax and
can be inhibited by antiapoptotic mem-
bers of the bcl-2 family or by members of
the IAP family (Hengartner, 2000). Thus,
the decision to live or die after an insult is
often determined by the balance of pro-
and antiapoptotic proteins in a cell.
PCD also protects cells from malig-
nant transformation. In the event of
severe DNA damage, apoptosis pre-
vents the survival of cells that have accu-
mulated potentially cancer-inducing
mutations. Furthermore, many of the
events that lead the deregulation of cel-
lular proliferation also trigger apoptosis.
Not surprisingly, many of the mutations
that lead to malignant transformation
occur in genes that regulate PCD. The
fusion protein, E2A-HLF, found in a rare
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Programmed cell death (PCD) plays an important role in normal and malignant hematopoiesis. In this issue of Cancer Cell,
Inoue et al. (2002) demonstrate that the CED-1 homolog, Slug, is a key regulator of apoptosis in the response of early
hematopoietic progenitors to γ radiation.
Figure 1. Proposed model for normal
hematopoietic maturation in the adult
mouse
In this model, the population of normal
hematopoietic cells capable of multilineage
reconstitution of a lethally irradiated host is
strictly contained within two identifiable and
separate population of cells: the long-term
hematopoietic stem cell and the short-term
hematopoietic stem cell. Using flow cytome-
try, Inoue et al. isolated enriched popula-
tions of LT-HSCs and ST-HSCs as well as popu-
lations of committed progenitors. They then
examined the expression of Slug, as well as
GATA-2, in 2000 cell aliquots using RT-PCR
with primers specific for Slug and GATA-2. As
shown here, they demonstrated the expres-
sion of Slug in both LT-HSC and ST-HSC as well
as the committed progenitors of the myeloid
series. Slug was not detected in beyond the
earliest identifiable lymphoid progenitor,
CLP, or in terminally differentiated peripheral
blood elements.
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form of chemotherapy-resistant B cell
ALL, contains the N-terminal domains of
E2A fused with the C-terminal basic
region and leucine zipper domain of HLF.
E2A-HLF retains both the DNA binding
capacity of HLF and transcriptional acti-
vation domains of E2A. In C. elegans,
CES-2 has a DNA binding domain
homologous to that of HLF and has been
shown to be involved in the regulation of
neuronal apoptosis.
In 1999, Inukai et al. identified Slug
as a downstream target of the E2A-HLF
(Inukai et al., 1999). By amino acid
analysis, SLUG is a homolog of CES-1,
the downstream target of CES-2 in C.
elegans. Since CES-1 and CES-2 regu-
late apoptosis in the worm, the capacity
of Slug to inhibit apoptosis following
growth factor withdrawal was tested.
IL-3-dependent BAF3 cells were infected
with a retrovirus that expressed the
murine Slug. Following withdrawal of 
IL-3, BAF-3 cells expressing Slug were
shown to have a prolonged survival with
the antiapoptotic activity of Slug
approaching that of Bcl-2 and Bcl-xL.
In the current paper, Inoue et al.
examine the effects of Slug in normal
hematopoiesis. Slug−/− mice were viable
and demonstrated only mild growth
retardation as well as eyelid deformities.
Examination of the peripheral blood
compartment demonstrated equivalent
numbers of mature lympho-hematopoiet-
ic cells, but there was a 2-fold increase in
the number of hematopoietic colony-
forming progenitors compared to wild-
type litter mates. Since colony scoring
was performed relatively early post cul-
ture, days 3 and 7, there may have been
a bias toward later progenitors. The
authors hypothesize that the increased
colony formation in Slug−/− is likely due to
expansion of the progenitor pools to
maintain normal levels of mature blood
cells in the peripheral blood. Analysis of
the numbers of specific progenitor cells
by flow cytometry will be needed for con-
firmation (Morrison et al., 1995; Akashi
et al., 2000a, 2000b).
In C. elegans, CES-2 and CES-1, the
orthologs of HLF and Slug, are involved in
the developmentally regulated cell death
of two serotonergic neurons. In this sys-
tem, CES-1 represses the expression of
downstream genes required for cell death
signaling and is regulated by CES-2. To
examine the role of Slug in vertebrate cel-
lular responses to DNA damage, the
authors then studied the effects of γ radia-
tion on the hematopoietic system of Slug−/−
mice. Wild-type mice exposed to 8 Gy of
total body irradiation demonstrated a sur-
vival rate of 50%; in contrast, all Slug−/−
mice died following this dose of radiation.
Studies of the peripheral blood of mori-
bund mice as well as pathologic studies of
the Slug−/− mice post radiation suggested
bone marrow aplasia as the likely cause
of mortality.This conclusion was strength-
ened by the observation that a single
dose of the hematopoietic growth factor
Peg-rmMGDF protected Slug−/− mice
against γ radiation-induced cell death.
In thymocytes, γ radiation-induced
cell death has been shown to be p53
dependent. The authors therefore ana-
lyzed the radiosensitivity of bone marrow
cells and thymocytes of Slug−/− mice. In
contrast to the bone marrow cells, the
thymocytes were equally sensitive to γ
irradiation as wild-type littermates.
Furthermore, there was no difference in
the expression of p53 in either cell type
in Slug−/− and wild-type mice after irradia-
tion. These studies suggest that a key
function of Slug is the protection of
hematopoietic progenitors against cell
death following DNA damage via a
mechanism other than p53.
To begin to understand which cells
are protected by Slug, TUNEL assays
were done using Lineage+ as well as
Lineage-depleted bone marrow cells
from Slug−/− and wild-type mice following
γ irradiation. Compared to wild-type litter-
mates, Slug−/− mice had increased levels
of TUNEL+ cells (56.8% ± 9.7% versus
30.3% ± 12.5%). By TUNEL assay, lin-
eage-positive cells from both sets of ani-
mals were equally resistant to γ irradia-
tion. In addition, the expression of Slug
was increased in the Lineage-negative
fraction of wild-type mice following γ irra-
diation, suggesting that Slug is directly
induced by DNA-damaging effects of γ
irradiation in normal animals. Consistent
with this observation, Slug was found to
be expressed at higher levels in the stem
and early progenitor cells than in more
mature hematopoietic cells.
These studies strongly implicate Slug
as an important inhibitor of apoptosis in
the hematopoietic system following DNA
damage via a p53-independent pathway.
The rapid decline in peripheral cell counts
and early deaths seen in the Slug−/− mice
are consistent with a profound loss of
committed progenitors by the irradiated
mice (Na Nakorn et al., 2002). This is
supported by the TUNEL assays. Since
stem cells comprise only ?1/1000 of
Lineage cells, most of the large number
TUNEL+ cells seen in the authors’ study
must have been progenitor cells. While
they determined that Slug is expressed in
the HSC, its role in inhibition of HSC
apoptosis following γ irradiation was not
addressed in this study. Future studies
will hopefully address the role of Slug in
inhibiting apoptosis in the HSC.
The data presented are intriguing
and offer insight into the mechanisms
protecting hematopoietic progenitor cells
from γ irradiation-induced apoptosis.
Potentially as interesting would be the
role of Slug in mediating apoptosis fol-
lowing other agents capable of inducing
similar levels of DNA damage, i.e.,
chemotherapy. Slug was initially identi-
fied following representational difference
analysis with an E2A-HLF-positive
human leukemic cell line. An important
clinical feature of this cytogenetic abnor-
mality is its association with leukemias
highly refractory to chemotherapy. This
suggests that Slug may play a role in
inhibiting apoptosis following exposure
to other cytotoxic agents. In their initial
study, Inukai et al. (1999) examined pri-
mary samples from patients with acute
leukemia and determined that Slug
expression was found only in patients
possessing the E2A-HLF abnormality.
This suggests that Slug is not a common
means of developing resistance to
chemotherapy in acute leukemia. More
interesting, if Slug is important in inhibit-
ing apoptosis following cytotoxic thera-
pies in normal but not malignant
hematopoiesis, perhaps it represents a
target for therapies designed at protect-
ing patients from the morbidities associ-
ated with their treatment.
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Metastasis is the primary cause of mor-
bidity and mortality for patients with can-
cer. While it has been recognized for
many years that movement of neoplastic
cells is not a random
process, the molecular and
cellular mechanisms govern-
ing their movement, survival
through foreign tissue envi-
ronments, and parameters
for choosing and taking up
residence at a final destina-
tion have remained uncer-
tain. Several contrasting the-
ories have emerged to
explain metastatic specificity.
The “homing” theory sug-
gests that organs distal to
sites of primary malignancy
actively attract and/or arrest
(“trap”) malignant cells via
expression of adhesion
receptors, e.g., selectins, or
by secretion of soluble
chemotactic factors, e.g.,
chemokines. Indeed, there is
good experimental evidence
implicating chemokine recep-
tors and their ligands for the
chemoattraction aspect of
the homing theory (Muller et
al., 2001; Wilson and
Balkwill, 2002). In addition,
identification of “molecular
addresses” or adhesion
receptors on endothelial cells
in vascular beds of distal
organs that specifically trap
circulating malignant cells
supports the active “arrest”
view of homing (Borsig et al.,
2002; Laakkonen et al.,
2002). In contrast, the “fertile
soil” theory proposes that different organ
environments provide optimal growth
conditions for specific circulating cell
types. Since underlying mechanisms
supporting these theories are not mutu-
ally exclusive, it seems likely that distinct
mechanisms/molecules might govern a
malignant cells journey to an ectopic 
tissue, separate from those
regulating its growth and/or
survival once its destination
has been achieved. An excit-
ing observation by Shibuyu
and colleagues (Hiratsuka et
al., 2002 [this issue of Cancer
Cell]) provides some clues
into the later aspects of 
the metastatic cascade impli-
cating an extracellular metal-
loproteinase, e.g., matrix
metalloproteinase-9 (MMP9),
made by tumor-associated
macrophages (TAMs) and
alveolar endothelial cells, in
microenvironmental remodel-
ing necessary for metastatic
cell survival in the lung.
Tumor cells produce 
various cytokines and
chemokines that attract
leukocytes (macrophages,
neutrophils, dendritic cells,
eosinophils, and mast cells)
that are variably loaded 
with molecules affecting pri-
mary neoplastic growth, e.g.,
cytokines, cytotoxic media-
tors, serine-, cysteine-, and
m e t a l l o - p r o t e a s e s ,  
membrane-perforating agents,
and soluble mediators of cell
killing, such as tumor necro-
sis factor-α (TNF-α), inter-
leukins (IL), and interferons
(IFNs) (Wilson and Balkwill,
2002). TAMs play a dual role
in neoplasms.Whereas TAMs
MMP9 potentiates pulmonary metastasis formation
Tumor cell dissemination to distant organ sites is a complex process involving multiple cell types, soluble growth factors,
adhesion receptors, and tissue remodeling. A new study in this issue of Cancer Cell shows that MMP9-expressing tumor-
associated macrophages play a key role in prepping premetastatic sites for eventual malignant cell growth in a manner
dependent upon vascular endothelial growth factor receptor-1 (VEGFR-1).
Figure 1. A model for the role of tumor-associated macrophages and
MMP9 in priming premetastatic tissue
Macrophages (Mφ) are recruited to sites of malignant growth. Upon
activation by primary tumor (PT) cells, activated macrophages (Mφ*)
expressing MMP9 then reenter the circulation and induce MMP9
expression in (alveolar) endothelial cells (Alv. EC) in a VEGFR-1-
dependent manner, thereby prepping premetastatic tissue for malig-
nant cell colonization. Distal organs harboring low-level VEGFR-1
expression are not suitable environments for metastatic growth and
fail to induce MMP9 expression in response to the presence of activat-
ed macrophages.
